These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32925363)

  • 21. Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda.
    van Griensven J; Zachariah R; Rasschaert F; Mugabo J; Atté EF; Reid T
    Trans R Soc Trop Med Hyg; 2010 Feb; 104(2):148-53. PubMed ID: 19732926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral neuropathy during stavudine-didanosine antiretroviral therapy.
    Reliquet V; Mussini JM; Chennebault JM; Lafeuillade A; Raffi F
    HIV Med; 2001 Apr; 2(2):92-6. PubMed ID: 11737385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Excess peripheral neuropathy in patients treated with hydroxyurea plus didanosine and stavudine for HIV infection.
    Cepeda JA; Wilks D
    AIDS; 2000 Feb; 14(3):332-3. PubMed ID: 10716516
    [No Abstract]   [Full Text] [Related]  

  • 24. Sex differences in the incidence of peripheral neuropathy among Kenyans initiating antiretroviral therapy.
    Mehta SA; Ahmed A; Laverty M; Holzman RS; Valentine F; Sivapalasingam S
    Clin Infect Dis; 2011 Sep; 53(5):490-6. PubMed ID: 21844033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial.
    Kiwuwa-Muyingo S; Kikaire B; Mambule I; Musana H; Musoro G; Gilks CF; Levin JB; Walker AS
    AIDS; 2014 Nov; 28(17):2579-88. PubMed ID: 25574960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3.
    Pollard RB; Peterson D; Hardy D; Pottage J; Murphy RL; Gathe J; Beall G; Rutkievicz V; Reynolds L; Cross AP; Dunkle LM
    J Acquir Immune Defic Syndr; 1999 Sep; 22(1):39-48. PubMed ID: 10534145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral neuropathy in patients with human immunodeficiency viral infection at a tertiary hospital in Ghana.
    Puplampu P; Ganu V; Kenu E; Kudzi W; Adjei P; Grize L; Käser M
    J Neurovirol; 2019 Aug; 25(4):464-474. PubMed ID: 31028691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of stavudine-based antiretroviral therapy on the severity of polyneuropathy in HIV/AIDS patients: a preliminary report from Zaria, Northern Nigeria.
    Obiako OR; Abdu-Aguye I; Ogunniyi A
    West Afr J Med; 2011; 30(5):354-8. PubMed ID: 22752824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalent neuropathy in a cohort of HIV-infected Kenyan sex workers using antiretroviral drugs.
    Ndakala FN; Oyugi JO; Oluka MN; Kimani J; Jablonka A; Behrens GM
    Pan Afr Med J; 2016; 25():14. PubMed ID: 28154706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral neuropathy in patients with HIV infection: consider dual pathology.
    Miller RF; Bunting S; Sadiq ST; Manji H
    Sex Transm Infect; 2002 Dec; 78(6):462-3. PubMed ID: 12473814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stavudine: an update of its use in the treatment of HIV infection.
    Hurst M; Noble S
    Drugs; 1999 Nov; 58(5):919-49. PubMed ID: 10595868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time for a change?
    Little S; del Rio C
    AIDS Clin Care; 1998 Dec; 10(12):92, 98. PubMed ID: 11366070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV neuropathy in pre-HAART patients and it's correlation with risk factors in Central India.
    Dubey TN; Raghuvanshi SS; Sharma H; Saxena R
    Neurol India; 2013; 61(5):478-80. PubMed ID: 24262448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral neuropathy in children on stauvudine therapy.
    Sankhyan N; Lodha R; Sharma S; Menon PR; Choudhary A; Kabra SK; Gulati S
    Indian J Pediatr; 2015 Feb; 82(2):136-9. PubMed ID: 24874810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda.
    Forna F; Liechty CA; Solberg P; Asiimwe F; Were W; Mermin J; Behumbiize P; Tong T; Brooks JT; Weidle PJ
    J Acquir Immune Defic Syndr; 2007 Apr; 44(4):456-62. PubMed ID: 17279048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV neuropathy in South Africans: frequency, characteristics, and risk factors.
    Maritz J; Benatar M; Dave JA; Harrison TB; Badri M; Levitt NS; Heckmann JM
    Muscle Nerve; 2010 May; 41(5):599-606. PubMed ID: 20229576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe toxicity and polymerase-γ gene abnormalities in Malawian adults on stavudine-based antiretroviral therapy.
    van Oosterhout JJ; Gardner K; Mallewa J; Kaunda S; Kampira E; Payne B; Heyderman RS; Chinnery P
    Pharmacogenet Genomics; 2013 Nov; 23(11):624-6. PubMed ID: 23962909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial DNA subhaplogroups L0a2 and L2a modify susceptibility to peripheral neuropathy in malawian adults on stavudine containing highly active antiretroviral therapy.
    Kampira E; Kumwenda J; van Oosterhout JJ; Dandara C
    J Acquir Immune Defic Syndr; 2013 Aug; 63(5):647-52. PubMed ID: 23614993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High prevalence of distal sensory polyneuropathy in antiretroviral-treated and untreated people with HIV in Tanzania.
    Mullin S; Temu A; Kalluvya S; Grant A; Manji H
    Trop Med Int Health; 2011 Oct; 16(10):1291-6. PubMed ID: 21707880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stavudine and the peripheral nerve in HIV-1 infected patients.
    von Giesen HJ; Hefter H; Jablonowski H; Arendt G
    J Neurol; 1999 Mar; 246(3):211-7. PubMed ID: 10323320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.